Systemic high-dose dexamethasone treatment may modulate the efficacy of intratumoral viral oncolytic immunotherapy in glioblastoma models
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2022-01-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/10/1/e003368.full |
| _version_ | 1818955429808439296 |
|---|---|
| author | Francesca Barone Paul P Tak Sean Lawler James A Lederer Marilin S Koch Mykola Zdioruk Michal O Nowicki Alec M Griffith Estuardo Aguilar Laura K Aguilar Brian W Guzik E Antonio Chiocca |
| author_facet | Francesca Barone Paul P Tak Sean Lawler James A Lederer Marilin S Koch Mykola Zdioruk Michal O Nowicki Alec M Griffith Estuardo Aguilar Laura K Aguilar Brian W Guzik E Antonio Chiocca |
| author_sort | Francesca Barone |
| collection | DOAJ |
| first_indexed | 2024-12-20T10:37:56Z |
| format | Article |
| id | doaj.art-06519b4a8e9e4394bfe536ab62aa59b5 |
| institution | Directory Open Access Journal |
| issn | 2051-1426 |
| language | English |
| last_indexed | 2024-12-20T10:37:56Z |
| publishDate | 2022-01-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | Journal for ImmunoTherapy of Cancer |
| spelling | doaj.art-06519b4a8e9e4394bfe536ab62aa59b52022-12-21T19:43:35ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262022-01-0110110.1136/jitc-2021-003368Systemic high-dose dexamethasone treatment may modulate the efficacy of intratumoral viral oncolytic immunotherapy in glioblastoma modelsFrancesca Barone0Paul P Tak1Sean Lawler2James A Lederer3Marilin S Koch4Mykola Zdioruk5Michal O Nowicki6Alec M Griffith7Estuardo Aguilar8Laura K Aguilar9Brian W Guzik10E Antonio Chiocca116 RRG, Institute of Inflamation and Ageing, University of Birmingham, Birmingham, UK, UK1 Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands1Brigham and Women’s Hospital, Boston, MA, USA1Brigham and Women’s Hospital and Harvard Medical School, USADepartment of Neurosurgery, Brigham and Women`s Hospital, Boston, Massachusetts, USADepartment of Neurosurgery, Brigham and Women`s Hospital, Boston, Massachusetts, USADepartment of Neurosurgery, Brigham and Women`s Hospital, Boston, Massachusetts, USAHarvard Medical School, Boston, Massachusetts, USACandel Therapeutics, Needham, Massachusetts, USACandel Therapeutics, Needham, Massachusetts, USACandel Therapeutics, Needham, Massachusetts, USADepartment of Neurosurgery, Brigham and Women`s Hospital, Boston, Massachusetts, USAhttps://jitc.bmj.com/content/10/1/e003368.full |
| spellingShingle | Francesca Barone Paul P Tak Sean Lawler James A Lederer Marilin S Koch Mykola Zdioruk Michal O Nowicki Alec M Griffith Estuardo Aguilar Laura K Aguilar Brian W Guzik E Antonio Chiocca Systemic high-dose dexamethasone treatment may modulate the efficacy of intratumoral viral oncolytic immunotherapy in glioblastoma models Journal for ImmunoTherapy of Cancer |
| title | Systemic high-dose dexamethasone treatment may modulate the efficacy of intratumoral viral oncolytic immunotherapy in glioblastoma models |
| title_full | Systemic high-dose dexamethasone treatment may modulate the efficacy of intratumoral viral oncolytic immunotherapy in glioblastoma models |
| title_fullStr | Systemic high-dose dexamethasone treatment may modulate the efficacy of intratumoral viral oncolytic immunotherapy in glioblastoma models |
| title_full_unstemmed | Systemic high-dose dexamethasone treatment may modulate the efficacy of intratumoral viral oncolytic immunotherapy in glioblastoma models |
| title_short | Systemic high-dose dexamethasone treatment may modulate the efficacy of intratumoral viral oncolytic immunotherapy in glioblastoma models |
| title_sort | systemic high dose dexamethasone treatment may modulate the efficacy of intratumoral viral oncolytic immunotherapy in glioblastoma models |
| url | https://jitc.bmj.com/content/10/1/e003368.full |
| work_keys_str_mv | AT francescabarone systemichighdosedexamethasonetreatmentmaymodulatetheefficacyofintratumoralviraloncolyticimmunotherapyinglioblastomamodels AT paulptak systemichighdosedexamethasonetreatmentmaymodulatetheefficacyofintratumoralviraloncolyticimmunotherapyinglioblastomamodels AT seanlawler systemichighdosedexamethasonetreatmentmaymodulatetheefficacyofintratumoralviraloncolyticimmunotherapyinglioblastomamodels AT jamesalederer systemichighdosedexamethasonetreatmentmaymodulatetheefficacyofintratumoralviraloncolyticimmunotherapyinglioblastomamodels AT marilinskoch systemichighdosedexamethasonetreatmentmaymodulatetheefficacyofintratumoralviraloncolyticimmunotherapyinglioblastomamodels AT mykolazdioruk systemichighdosedexamethasonetreatmentmaymodulatetheefficacyofintratumoralviraloncolyticimmunotherapyinglioblastomamodels AT michalonowicki systemichighdosedexamethasonetreatmentmaymodulatetheefficacyofintratumoralviraloncolyticimmunotherapyinglioblastomamodels AT alecmgriffith systemichighdosedexamethasonetreatmentmaymodulatetheefficacyofintratumoralviraloncolyticimmunotherapyinglioblastomamodels AT estuardoaguilar systemichighdosedexamethasonetreatmentmaymodulatetheefficacyofintratumoralviraloncolyticimmunotherapyinglioblastomamodels AT laurakaguilar systemichighdosedexamethasonetreatmentmaymodulatetheefficacyofintratumoralviraloncolyticimmunotherapyinglioblastomamodels AT brianwguzik systemichighdosedexamethasonetreatmentmaymodulatetheefficacyofintratumoralviraloncolyticimmunotherapyinglioblastomamodels AT eantoniochiocca systemichighdosedexamethasonetreatmentmaymodulatetheefficacyofintratumoralviraloncolyticimmunotherapyinglioblastomamodels |